454 related articles for article (PubMed ID: 22361515)
1. Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features.
Ariga T
Allergol Int; 2012 Jun; 61(2):183-9. PubMed ID: 22361515
[TBL] [Abstract][Full Text] [Related]
2. Wiskott-Aldrich syndrome.
Notarangelo LD; Miao CH; Ochs HD
Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular characterization of Thai patients with Wiskott-Aldrich syndrome.
Amarinthnukrowh P; Ittiporn S; Tongkobpetch S; Chatchatee P; Sosothikul D; Shotelersuk V; Suphapeetiporn K
Scand J Immunol; 2013 Jan; 77(1):69-74. PubMed ID: 23033889
[TBL] [Abstract][Full Text] [Related]
4. [Wiskott-Aldrich syndrome].
Gulácsy V; Maródi L
Orv Hetil; 2008 Jul; 149(29):1367-71. PubMed ID: 18617469
[TBL] [Abstract][Full Text] [Related]
5. Detection of six novel mutations in WASP gene in fifteen Iranian Wiskott-Aldrich patients.
Safaei S; Fazlollahi MR; Houshmand M; Hamidieh AA; Bemanian MH; Alavi S; Mousavi F; Pourpak Z; Moin M
Iran J Allergy Asthma Immunol; 2012 Dec; 11(4):345-8. PubMed ID: 23264413
[TBL] [Abstract][Full Text] [Related]
6. The genotype of the original Wiskott phenotype.
Binder V; Albert MH; Kabus M; Bertone M; Meindl A; Belohradsky BH
N Engl J Med; 2006 Oct; 355(17):1790-3. PubMed ID: 17065640
[TBL] [Abstract][Full Text] [Related]
7. Current and emerging treatment options for Wiskott-Aldrich syndrome.
Worth AJ; Thrasher AJ
Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
[TBL] [Abstract][Full Text] [Related]
8. The Wiskott-Aldrich syndrome.
Ochs HD; Thrasher AJ
J Allergy Clin Immunol; 2006 Apr; 117(4):725-38; quiz 739. PubMed ID: 16630926
[TBL] [Abstract][Full Text] [Related]
9. Wiskott-Aldrich syndrome is an important differential diagnosis in male infants with juvenile myelomonocytic leukemialike features.
Watanabe N; Yoshimi A; Kamachi Y; Kawabe T; Muramatsu H; Matsumoto K; Manabe A; Kojima S; Kato K
J Pediatr Hematol Oncol; 2007 Dec; 29(12):836-8. PubMed ID: 18090932
[TBL] [Abstract][Full Text] [Related]
10. Two novel mutations identified in the Wiskott-Aldrich syndrome protein gene cause Wiskott-Aldrich syndrome and thrombocytopenia.
Andreu N; Matamoros N; Escudero A; Fillat C
Int J Mol Med; 2007 May; 19(5):777-82. PubMed ID: 17390083
[TBL] [Abstract][Full Text] [Related]
11. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Boztug K; Dewey RA; Klein C
Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
[TBL] [Abstract][Full Text] [Related]
12. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.
Liu DW; Zhang ZY; Zhao Q; Jiang LP; Liu W; Tu WW; Song WX; Zhao XD
Pediatr Blood Cancer; 2015 Sep; 62(9):1601-8. PubMed ID: 25931402
[TBL] [Abstract][Full Text] [Related]
13. A case of Wiskott-Aldrich syndrome with de novo mutation at exon 4.
Doğu F; Ariga T; Ikincioğullari A; Bozdoğan G; Aytekin C; Metin A; Babacan E
Turk J Pediatr; 2006; 48(1):66-8. PubMed ID: 16562789
[TBL] [Abstract][Full Text] [Related]
14. Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.
Candotti F
J Clin Immunol; 2018 Jan; 38(1):13-27. PubMed ID: 29086100
[TBL] [Abstract][Full Text] [Related]
15. A unique presentation of Wiskott-Aldrich syndrome in relation to platelet size.
Patel PD; Samanich JM; Mitchell WB; Manwani D
Pediatr Blood Cancer; 2011 Jul; 56(7):1127-9. PubMed ID: 21488158
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
Itoh S; Nonoyama S; Morio T; Imai K; Okawa H; Ochs HD; Shimadzu M; Yata J
Int J Hematol; 2000 Jan; 71(1):79-83. PubMed ID: 10729999
[TBL] [Abstract][Full Text] [Related]
17. Identification of WASP mutations in 10 Australian families with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
Bourne HC; Weston S; Prasad M; Edkins E; Benson EM
Pathology; 2004 Jun; 36(3):262-4. PubMed ID: 15203732
[TBL] [Abstract][Full Text] [Related]
18. Detection of 28 novel mutations in the Wiskott-Aldrich syndrome and X-linked thrombocytopenia based on multiplex PCR.
Proust A; Guillet B; Picard C; de Saint Basile G; Pondarré C; Tamary H; Dreyfus M; Tchernia G; Fischer A; Delaunay J
Blood Cells Mol Dis; 2007; 39(1):102-6. PubMed ID: 17400488
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
20. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment.
Ochs HD; Filipovich AH; Veys P; Cowan MJ; Kapoor N
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):84-90. PubMed ID: 19147084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
